Gregory Gaich

6.3k total citations · 2 hit papers
13 papers, 4.7k citations indexed

About

Gregory Gaich is a scholar working on Oncology, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Gregory Gaich has authored 13 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 5 papers in Molecular Biology and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Gregory Gaich's work include Bone health and treatments (7 papers), Bone health and osteoporosis research (4 papers) and Fibroblast Growth Factor Research (3 papers). Gregory Gaich is often cited by papers focused on Bone health and treatments (7 papers), Bone health and osteoporosis research (4 papers) and Fibroblast Growth Factor Research (3 papers). Gregory Gaich collaborates with scholars based in United States, Canada and Australia. Gregory Gaich's co-authors include Anthony B. Hodsman, Jean‐Yves Reginster, Richard L. Prince, Sophia Ish‐Shalom, José Zanchetta, Harry K. Genant, Ouhong Wang, Claude D. Arnaud, Erik Fink Eriksen and Bruce Mitlak and has published in prestigious journals such as New England Journal of Medicine, The Journal of Clinical Endocrinology & Metabolism and Cell Metabolism.

In The Last Decade

Gregory Gaich

12 papers receiving 4.6k citations

Hit Papers

Effect of Parathyroid Hormone (1-34) on Fractures and Bon... 2001 2026 2009 2017 2001 2013 1000 2.0k 3.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Effect of Parathyroid Hormone (1-34) on Fractures and Bone Mineral Density in Postmenopausal Women with Osteoporosis
    2001 3.4k citations Robert M. Neer, Claude D. Arnaud et al. New England Journal of Medicine profile →
  2. The Effects of LY2405319, an FGF21 Analog, in Obese Human Subjects with Type 2 Diabetes
    2013 730 citations Gregory Gaich, Jenny Y. Chien et al. Cell Metabolism profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gregory Gaich United States 10 2.9k 2.4k 2.4k 818 438 13 4.7k
Ouhong Wang United States 10 3.1k 1.1× 1.9k 0.8× 2.5k 1.1× 802 1.0× 510 1.2× 14 4.4k
Suresh Siddhanti United States 24 3.2k 1.1× 2.3k 1.0× 2.9k 1.2× 660 0.8× 302 0.7× 54 4.7k
Mark P. Ettinger United States 23 2.3k 0.8× 966 0.4× 1.8k 0.7× 731 0.9× 202 0.5× 30 3.4k
Jorma Salmi Finland 27 2.5k 0.9× 1.7k 0.7× 2.1k 0.9× 1.5k 1.9× 434 1.0× 55 5.6k
Robert W. Downs United States 33 3.5k 1.2× 2.3k 0.9× 2.9k 1.2× 1.2k 1.5× 964 2.2× 69 6.6k
David Hosking United Kingdom 28 2.4k 0.8× 959 0.4× 2.4k 1.0× 465 0.6× 223 0.5× 59 3.7k
John L. Stock United States 23 1.8k 0.6× 940 0.4× 1.3k 0.5× 643 0.8× 349 0.8× 59 2.9k
Masahiro Yamamoto Japan 29 1.6k 0.6× 1.3k 0.5× 1.0k 0.4× 389 0.5× 283 0.6× 80 3.2k
Arkadi Chines United States 43 4.5k 1.6× 2.1k 0.9× 3.5k 1.5× 614 0.8× 278 0.6× 102 6.5k
P. Lakatos Hungary 25 1.1k 0.4× 757 0.3× 1.1k 0.5× 305 0.4× 439 1.0× 108 2.6k

Countries citing papers authored by Gregory Gaich

Since Specialization
Citations

This map shows the geographic impact of Gregory Gaich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory Gaich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory Gaich more than expected).

Fields of papers citing papers by Gregory Gaich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory Gaich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory Gaich. The network helps show where Gregory Gaich may publish in the future.

Co-authorship network of co-authors of Gregory Gaich

This figure shows the co-authorship network connecting the top 25 collaborators of Gregory Gaich. A scholar is included among the top collaborators of Gregory Gaich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregory Gaich. Gregory Gaich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Bilic, Sanela, Yossi Dagon, Thomas A. Gustafson, et al.. (2022). OR03-2 Phase 1, Randomized, Controlled Trial of GFB-024, a Once-Monthly CB1 Inverse Agonist, in Healthy Overweight and Obese Participants and in Participants with Type 2 Diabetes Mellitus. Journal of the Endocrine Society. 6(Supplement_1). A348–A348. 1 indexed citations
2.
3.
Gaich, Gregory, Jenny Y. Chien, Haoda Fu, et al.. (2013). The Effects of LY2405319, an FGF21 Analog, in Obese Human Subjects with Type 2 Diabetes. Cell Metabolism. 18(3). 333–340. 730 indexed citations breakdown →
4.
Jesudason, Cynthia D., James E. Baker, Libbey S. O′Farrell, et al.. (2011). Combination of a Beta Adrenoceptor Modulator and a Norepinephrine-Serotonin Uptake Inhibitor for the Treatment of Obesity. ACS Medicinal Chemistry Letters. 2(8). 583–586. 2 indexed citations
5.
Ste-Marie, L.-G., Sherwyn Schwartz, Anwar Hossain, D. Desaiah, & Gregory Gaich. (2006). Effect of Teriparatide {rhPTH(1-34)} on BMD When Given to Postmenopausal Women Receiving Hormone Replacement Therapy. Journal of Bone and Mineral Research. 21(2). 283–291. 36 indexed citations
6.
Body, Jean‐Jacques, Gregory Gaich, Wim H. Scheele, et al.. (2002). A Randomized Double-Blind Trial to Compare the Efficacy of Teriparatide [Recombinant Human Parathyroid Hormone (1–34)] with Alendronate in Postmenopausal Women with Osteoporosis. The Journal of Clinical Endocrinology & Metabolism. 87(10). 4528–4535. 277 indexed citations
7.
Neer, Robert M., Claude D. Arnaud, José Zanchetta, et al.. (2001). Effect of Parathyroid Hormone (1-34) on Fractures and Bone Mineral Density in Postmenopausal Women with Osteoporosis. New England Journal of Medicine. 344(19). 1434–1441. 3366 indexed citations breakdown →
8.
Neer, Robert M., Claude D. Arnaud, José Zanchetta, et al.. (2001). Effect of Parathyroid Hormone (1-34) on Fractures and Bone Mineral Density in Postmenopausal Women With Osteoporosis. Obstetrical & Gynecological Survey. 56(10). 623–624. 191 indexed citations
9.
Burtis, William J., Pamela Dann, Gregory Gaich, & Neil E. Soifer. (1994). A high abundance midregion species of parathyroid hormone-related protein: immunological and chromatographic characterization in plasma.. The Journal of Clinical Endocrinology & Metabolism. 78(2). 317–322. 23 indexed citations
10.
Gaich, Gregory, et al.. (1994). Thyrotropin-Secreting Adenoma in an Adolescent Girl without Increased Serum Thyrotropin-alpha. Hormone Research. 42(3). 120–123. 11 indexed citations
11.
Gaich, Gregory, et al.. (1993). Amino-terminal parathyroid hormone-related protein: specific binding and cytosolic calcium responses in rat insulinoma cells.. Endocrinology. 132(3). 1402–1409. 42 indexed citations
12.
Burtis, William J., et al.. (1992). Preliminary characterization of circulating amino- and carboxy-terminal fragments of parathyroid hormone-related peptide in humoral hypercalcemia of malignancy.. The Journal of Clinical Endocrinology & Metabolism. 75(4). 1110–1114. 30 indexed citations
13.
Gaich, Gregory & William J. Burtis. (1991). The Diagnosis and Treatment of Malignancy-Associated Hypercalcemia. The Endocrinologist. 1(6). 371–379. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ouhong Wang Breakdown of academic impact, for papers by Suresh Siddhanti Breakdown of academic impact, for papers by Mark P. Ettinger Breakdown of academic impact, for papers by Jorma Salmi Breakdown of academic impact, for papers by Robert W. Downs Breakdown of academic impact, for papers by David Hosking Breakdown of academic impact, for papers by John L. Stock Breakdown of academic impact, for papers by Masahiro Yamamoto Breakdown of academic impact, for papers by Arkadi Chines Breakdown of academic impact, for papers by P. Lakatos
Rankless by CCL
2026